Postural orthostatic tachycardia syndrome (POTS) is a form of chronic orthostatic intolerance that primarily affects children and adolescents, leading to debilitating symptoms like lightheadedness, ...

Findings A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel ...

BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders and USWM LLC, a specialty pharmaceutical company ...

A recent review has shed new light on the management of pediatric postural orthostatic tachycardia syndrome (POTS), a chronic condition causing ...

Cessation of such therapy, followed by substitution therapy with doxazosin, may have then allowed heart failure symptoms to become manifest. Conversely, in the chlorthalidone group, such symptoms ...

A recent review has shed new light on the management of pediatric postural orthostatic tachycardia syndrome (POTS), a chronic condition causing ...

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

A variety of antidotes have been reported to treat SSRI-induced sexual dysfunction effectively; however, virtually all the data on these agents are derived from open case reports and case series ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...